Device Trial Radar · NCT06675617
EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn
Last checked: Nov 20, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
72
Planned (sponsor's estimate)
Start
Oct 30, 2024
Primary completion
Jun 2027
Study completion Jun 2031
Sponsor
- Lead sponsor
- Intressa Vascular SANot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 5, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical trial is a prospective, multicenter, open label study designed to evaluate the effectiveness and the safety of the Allay® Aortic Stent as adjunctive endovascular treatment of Type B aortic dissection in patients eligible for thoracic endovascular aortic repair with stent grafts.
Conditions
- Type B Aortic Dissection
Interventions
Allay Aortic StentDevice
Endovascular treatment of an aortic dissection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from aortic growth requiring secondary reintervention, including open conversion, or aortic rupture in the region treated by the Allay® Aortic Stent at 12 monthsTime frame: 12 months
Locations
21 sites in 8 countries. Site status is shown where the registry gives one.
Paracelsus Medical University Salzburg
Salzburg, Austria · Not yet recruiting
Ziekenhuis Oost-Limburg
Genk, Belgium · Recruiting
UZ Leuven
Leuven, Belgium · Recruiting
18 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.